Quanterix is thrilled to announce its participation in ECTRIMS 2024 (European Committee for Treatment and Research in Multiple Sclerosis), scheduled to take place from September 18th to 20th, in Copenhagen, Denmark.

ECTRIMS 2024, the world’s largest MS research congress, is the premier meeting place for researchers, clinicians, and healthcare providers to collaborate on life-changing research and treatment options for people with MS and related diseases. Attracting an estimated 9,000 delegates from around the globe, this year’s event will feature an international range of speakers, including keynote lectures, oral and poster presentations, expertly selected scientific and educational sessions, and numerous networking opportunities.

Visit the Quanterix team at Booth #B37 to learn more about Simoa® technology and how our ultrasensitive biomarker detection is driving breakthroughs with its unparalleled sensitivity and flexibility.

Brain Exchange Speaking Session

Wednesday, September 18th at 13:50

Speaker: Prof. Dr. med. Dr. phil. Dr. Jens Kuhle, Research Center for Clinical Neuroimmunology and Neuroscience Basel

Topic: Advancing the Use of Blood Biomarkers in MS Practice: NfL and GFAP